The International Partnership for Microbicides' (IPM) 2016 Annual Report looks back at their monthly dapivirine ring to be the first microbicide and long-acting product to reduce women's risk of HIV in two Phase III trials. The report highlights the dapivirine ring and other milestones to add new tools to women's HIV prevention options.